For citations:
Sagoyan G.B., Suleymanova A.M., Rubanskaya M.V., Papyan R.Kh., Kirgizov K.I., Varfolomeeva S.R. Use of eflornithine (DFMO) in the treatment of children with high-risk neuroblastoma. Russian Journal of Pediatric Hematology and Oncology. 2025;12(3):80-84. (In Russ.) https://doi.org/10.21682/2311-1267-2025-12-3-80-84

























